The Harvard Drug Group to Implement Supply Chain Execution for Microsoft Axapta

ATLANTA, - Manhattan Associates® Inc. (Nasdaq: MANH - News), the global leader in providing supply chain execution and optimization solutions, has signed The Harvard Drug Group, LLC, a leading drug distribution company, as a customer through its partnership in the Microsoft® Business Solutions-Axapta® Industry Builder initiative. Harvard Drug will utilize Manhattan Associates' Warehouse Management solution for Windows, which includes warehouse management and transportation execution functionality. The deal was executed in conjunction with Winfosoft, a certified Microsoft Business Solutions partner.

Harvard Drug sought Manhattan Associates' Supply Chain Execution for Microsoft Axapta solution to improve track and trace capabilities, increase productivity and meet electronic pedigree requirements. Manhattan Associates' solutions extend the Microsoft Axapta business management suite for customers desiring superior supply chain execution and the deep functionality of its solutions capabilities.

"We were in final negotiations with SAP for their Business One product when Microsoft and Manhattan Associates announced their partnership," said Dwight Boothe, general manager and senior vice president of operations, Harvard Drug. "The leverage gained by combining the expertise of those two companies drove us to re-look at our initial decision. Once we saw the deep functionality of their combined solutions firsthand, we selected Manhattan Associates' Supply Chain Execution for Microsoft Axapta."

In order to comply with electronic pedigree regulations, Harvard Drug intends to implement this solution in a phased rollout across its entire distribution network. Harvard Drug will roll out Supply Chain Execution for Microsoft Axapta at its Indianapolis distribution center first and will then extend the rollout across its two other facilities. Additionally, its future plans include implementing RFID technology to further improve its track and trace capabilities.

"By leveraging certified Microsoft Business Solutions partners like Winfosoft, Microsoft and Manhattan Associates are able to expand the industry reach of Microsoft Axapta and offer companies like Harvard Drug the ability to deploy a comprehensive enterprise resource planning solution as well as warehouse management and transportation capabilities," said Jeff Sampson, senior business manager for Microsoft Axapta, Microsoft Business Solutions.

Microsoft Axapta utilizes Manhattan Associates' .NET-based Warehouse Management and Transportation Execution solutions to synchronize real-time product movement and improve productivity within customers' manufacturing and distribution operations. As part of the Industry Builder Initiative, these solutions are available to be marketed by more than 1,160 channel partners globally.

"Harvard Drug represents the continued success of our involvement with Microsoft and specifically with the Microsoft Axapta Industry Builder initiative," noted Jeff Mitchell, Manhattan Associates' executive vice president, Americas. "By replacing the manual processes currently in place at Harvard Drug, our solutions will allow them to establish a solid foundation for improving global inventory management."

For more information about Manhattan Associates, visit www.manh.com .